Stock OPHLY ONO PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Ono Pharmaceutical Co., Ltd. Share Price Other OTC

Equities

OPHLY

US6827361030

Pharmaceuticals

Financials

Sales 2024 503B 3.19B 266B Sales 2025 * 472B 3B 250B Capitalization 1,035B 6.58B 548B
Net income 2024 128B 813M 67.79B Net income 2025 * 99.21B 630M 52.55B EV / Sales 2024 2.29 x
Net cash position 2024 * 146B 925M 77.09B Net cash position 2025 * 191B 1.22B 101B EV / Sales 2025 * 1.79 x
P/E ratio 2024
9.21 x
P/E ratio 2025 *
10.5 x
Employees -
Yield 2024
3.26%
Yield 2025 *
3.63%
Free-Float 75.9%
More Fundamentals * Assessed data

Chart Ono Pharmaceutical Co., Ltd.

Dynamic Chart

Latest news about Ono Pharmaceutical Co., Ltd.

Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion RE
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon MT
Top Midday Gainers MT
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading MT
Sector Update: Health Care MT
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical MT
Deciphera Shares Hit 2-Year High After $2.4 Billion Buyout Offer From ONO Pharma DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal MT
Sector Update: Health Care MT
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal MT
Deciphera Pharmaceuticals Gets $2.4 Billion Buyout Offer From ONO Pharmaceutical DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal MT
Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion RE
Ono Pharmaceutical Co., Ltd. entered into a definitive merger agreement to acquire Deciphera Pharmaceuticals, Inc. for $2.2 billion. CI
More news

Latest transcript on Ono Pharmaceutical Co., Ltd.

Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd. - Special Call
More transcripts

Analyst Recommendations on Ono Pharmaceutical Co., Ltd.

Jefferies Adjusts Ono Pharmaceutical’s Price Target to 2,400 Yen From 2,300 Yen, Keeps at Hold MT
Jefferies Adjusts Ono Pharmaceutical’s Price Target to 2,300 Yen From 2,500 Yen, Keeps at Underperform MT
Jefferies Downgrades Ono Pharmaceuticals to Underperform From Hold, Adjusts Price Target to 2,500 Yen From 3,000 Yen MT
Jefferies Downgrades Ono Pharmaceuticals to Hold From Buy, Adjusts Price Target to 3,100 Yen From 4,300 Yen MT
ONO Selected as Highest Rating A-List Company by CDP in Two Categories of 'Climate Change' and 'Water Security' in CDP 2022 AQ
More recommendations

Press releases Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical : Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase) PU
Ono Pharmaceutical : Receives Approvals of BRAFTOVI® and MEKTOVI® for Expanded Use for Two New Indications in Japan PU
Ono Pharmaceutical : Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial PU
Ono Pharmaceutical : Notice regarding Differences in the Non-consolidated Financial Results between the Fiscal Year Ended March 31, 2024 and the Previous Fiscal Year PU
Ono Pharmaceutical : Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals PU
More press releases

News in other languages on Ono Pharmaceutical Co., Ltd.

El Nikkei cae un 0,5% arrastrado por los valores electrónicos y farmacéuticos -- Market Talk
El Nikkei cae un 0,4%, arrastrado por las farmacéuticas y las siderúrgicas -- Market Talk
Nuevas compras en la cartera Inversor Asia
Nouveaux achats dans le portefeuille Investisseur Asie
Nieuwe reeks stijgingen voor onze 3 selecties
More news

Managers and Directors - Ono Pharmaceutical Co., Ltd.

Managers TitleAgeSince
Gyo Sagara CEO
 Chief Executive Officer 65 01/83/01
Toichi Takino PSD
 President 55 -
Kazuhito Kawabata BRD
 Director/Board Member 64 01/85/01
Members of the board TitleAgeSince
Isao Ono BRD
 Director/Board Member 65 01/81/01
Shusaku Nagae BRD
 Director/Board Member 74 -
Gyo Sagara CEO
 Chief Executive Officer 65 01/83/01
More insiders

Company Profile

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.
Sector
Pharmaceuticals
Calendar
29/07/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+16.07% 42.25B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+17.73% 21.27B
SANDOZ GROUP AG Stock Sandoz Group AG
+16.67% 15.23B
CIPLA LIMITED Stock Cipla Limited
+18.92% 14.36B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+50.99% 12.74B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.28% 5.66B
GEDEON RICHTER Stock Gedeon Richter
+6.11% 4.8B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4528 Stock
  4. OPHLY Stock